We next investigated the relationship between DAB2IP expression levels and the clinicopathologic status of patients with gastric cancer and found that reduced DAB2IP in gastric cancer cells was significantly correlated with tumor size, lymph node metastasis, and TNM stage (Table 2). The gene discussed is DAB2IP; the disease is neoplasm.